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Many DNA-binding factors, such as transcription factors, form oligomeric complexes with 18 
structural symmetry that bind to palindromic DNA sequences 1.  Palindromic consensus 19 
nucleotide sequences are also found at the genomic integration sites of retroviruses 2-6 and 20 
other transposable elements 7-9, and it has been suggested that this palindromic consensus 21 
arises as a consequence of the structural symmetry in the integrase complex 2,3. However, we 22 
show here that the palindromic consensus sequence is not present in individual integration 23 
sites of Human T-cell Lymphotropic Virus type 1 (HTLV-1) and Human Immunodeficiency 24 
Virus type 1 (HIV-1), but arises in the population average as a consequence of the existence of 25 
a non-palindromic nucleotide motif that occurs in approximately equal proportions on the 26 
plus-strand and the minus-strand of the host genome. We develop a generally applicable 27 
algorithm to sort the individual integration site sequences into plus-strand and minus-strand 28 
subpopulations, and use this to identify the integration site nucleotide motifs of five 29 
retroviruses of different genera: HTLV-1, HIV-1, Murine Leukemia Virus (MLV), Avian 30 
Sarcoma Leucosis Virus (ASLV), and Prototype Foamy Virus (PFV). The results reveal a 31 
non-palindromic motif that is shared between these retroviruses.32 
Integration of a cDNA copy of the viral RNA genome is essential to establish infection 33 
by retroviruses. This process (see, for example, 10 for a review) is catalysed by the virus-encoded 34 
2 
enzyme integrase (IN) and is composed of two steps: (i) the 3’ processing reaction; and (ii) strand 35 
transfer. During the 3’ processing reaction, a di- or tri-nucleotide is removed from the 3’ ends of 36 
the viral long terminal repeats (LTRs) to expose the nucleophilic 3’OH groups that consequently 37 
attack the phosphodiester backbone of the target DNA during strand transfer. Strand transfer 38 
results in single-stranded DNA gaps that are filled in and repaired by host cellular enzymes.  39 
Depending on the retrovirus, the strand transfer reaction takes place with a 4 (e.g. MLV and 40 
prototype foamy virus, PFV), 5 (e.g. HIV-1) or 6 (e.g. HTLV-1 and 2) base pair stagger, giving 41 
rise to a duplication of the respective number of nucleotides at the integration site. 42 
 43 
 44 
Integration is not random:  each retrovirus has characteristic preferences for the genomic 45 
integration site (InS) (e.g. 11-15).  These preferences are evident on at least three scales: 46 
chromatin conformation and intranuclear location; proximity to specific genomic features such 47 
as transcription start sites or transcription factor binding sites; and the primary DNA sequence at 48 
the InS itself. Certain host factors also play an active part: t he best characterized of such factors 49 
are LEDGF 16,17, which biases HIV-1 integration into genes in preference to intergenic regions 18, 50 
and BET proteins, which direct MLV integration into the 5’ end of genes 10. 51 
 52 
  A nucleotide sequence is said to be palindromic if it is equal to its reverse complement 53 
(e.g. GAATTC and its complement, CTTAAG).  Previous studies have revealed a weak 54 
palindromic consensus sequence at the InS in several retroviral infections, including HTLV-1, 55 
ASLV, PFV, MLV, Simian Immunodeficiency Virus (SIV), and HIV-1 2,3,19-23. The reason for 56 
the presence of a palindromic consensus sequence remains unknown, but authors have 57 
speculated that it reflects the binding to the DNA of the pre-integration complex (PIC) in 58 
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symmetrical dimers or tetramers, so that each half-complex has a similar DNA target (i.e. 59 
potential integration site) preference 2.  However, the consensus sequence is a population 60 
average, defined by taking the modal nucleotide at each position in a population of InS 61 
sequences. The question arises whether or not the consensus is truly representative of the 62 
population. It may be a poor representation of the population if, for example, the population is 63 
highly variable or is composed of two or more distinct subpopulations (and hence is bi- or multi-64 
modal).  Retroviral InS sequences are known to be highly diverse, which immediately indicates 65 
the need for caution when interpreting the consensus. Here we perform statistical analyses to 66 
determine whether or not the palindromic consensus sequences efficiently represent the 67 
populations of InS sequences from which they are calculated.  We find strong evidence that this 68 
is not the case, and investigate the possibility that these palindromic consensus sequences arise 69 
from the presence of motif sequences that appear in both “forward” and “reverse complement” 70 
orientations in the genome. 71 
 72 
 73 
 74 
To depict the sequence of the consensus integration site motif, we calculated the frequency of 75 
each nucleotide at each respective position in the motif: the result, shown as a sequence logo 76 
(Figure 1), shows a clear palindrome for each virus, as previously described 2,3,19.  However, on 77 
close inspection an anomaly becomes evident: the sequence is palindromic not only in the most 78 
frequent nucleotide, but also at the 2nd, 3rd and (therefore) 4th nucleotide at every position.  79 
While it is plausible that the symmetry of the integrase complex should favor a palindromic 80 
motif in the nucleotides that make contacts with the integrase protein, it is not clear why the less 81 
frequent nucleotides across all positions in the motif should also be perfectly palindromic. 82 
 83 
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To quantify whether or not an individual sequence is palindromic, we defined the adjusted 84 
palindrome index (API), described further in Methods.  The API is 1 if the sequence is perfectly 85 
palindromic, 0 if the sequence is as palindromic as expected by chance, and negative if the 86 
sequence is less palindromic than expected by chance.  The APIs of the HTLV-1 and HIV-1 87 
motifs confirmed the very high palindromicity of the consensus sequence in each case (Figure 88 
2).  However, examination of the APIs of individual observed integration site sequences reveals 89 
a second anomaly: the mean values of the API across the populations of InS sequences are 90 
significantly less than zero, for both the HTLV-1 (Table 1) and HIV-1 (Table 2) InS sequences. 91 
Although the effect size is small (as might be expected given that the sequences are highly 92 
diverse), the key point is that, on average, the InS sequences are less palindromic than we would 93 
expect by random chance.   94 
 95 
How can a population of individually non-palindromic sequences generate a palindromic 96 
consensus motif?  We hypothesized that the retroviral integrase complex recognizes a non-97 
palindromic motif present either on the plus strand (“forward” orientation) or the minus strand 98 
(“reverse” orientation) of the host genome: the reverse complement of the minus-strand motif 99 
appears as the mirror image of the plus-strand motif, so that when the two are combined in a 100 
population of sequences, the consensus appears as a palindrome. 101 
 102 
To test this hypothesis, we fitted a model to resolve the population of observed integration sites 103 
into two components, one component corresponding to the subpopulation of sequences in the 104 
forward orientation and the other corresponding to those in the reverse orientation. We fitted the 105 
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model by maximum likelihood (see Methods for details of the model and fitting procedure, and 106 
Code Availability for an implementation).  We additionally considered a number of alternative 107 
algorithms for fitting the models (maximum profile likelihood and Gibbs sampling approaches), 108 
which provided qualitatively identical results (see Supplementary Figure 1).  For both HTLV-1 109 
and HIV-1, the algorithms identified complementary subpopulations within the collections of 110 
InS sequences (Figure 3a), with the subpopulations appearing in approximately equal 111 
proportions (λHTLV   = 0.47 and λHIV  = 0.49, where λ denotes the proportion of sequences in 112 
the “forward orientation”).  As a further check, we additionally considered an unconstrained 113 
clustering of the sequences, which also identified complementary clusters among the InS 114 
sequences (see Supplementary Figures 2 and 3). 115 
We next assessed whether the hypothesis of two complementary subpopulations provided a 116 
significantly better description of the data than the hypothesis of a single population 117 
characterized by a palindromic motif.  A likelihood ratio test (see Methods) decisively rejected 118 
the single-population hypothesis (p < 0.001).  We also calculated for each model the Bayesian 119 
Information Criterion 24 (BIC), which provides a measure of the ability of a model to explain the 120 
observed data.  The results again showed that for both HIV-1 and HTLV-1, there was very strong 121 
evidence against the one-population (palindromic) model (∆BICHIV= 2.86 × 103 and ∆BICHTLV= 122 
1.48 × 103). 123 
 124 
We fitted our 2-component mixture model to smaller datasets on HTLV-1, HIV-1, MLV, and 125 
ASLV taken from the literature 19. The results on MLV and ASLV are given in Figure 3b: the 126 
results on HTLV-1 and HIV-1 are qualitatively identical to those obtained from the larger 127 
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datasets, and are given in Supplementary Figure 4. We also considered two large PFV datasets 128 
from Maskell et al (2015) 25: (i) the PFV (WT) dataset, which comprises integration sites 129 
for 153,447 unique integration events in HT1080 cells; and (ii) the PFV (IV) dataset, comprising 130 
approximately 2 × 106 integration sites determined using purified PFV intasomes and 131 
deproteinized human DNA. 132 
 133 
After pre-processing to remove duplicates and sequences containing indeterminate nucleotides 134 
(Ns), 152,001 integration sites remained in the PFV (WT) dataset and 2,197,613 in the PFV (IV) 135 
dataset. To reduce computation time, we randomly sampled 200,000 integration site sequences 136 
from the PFV (IV) dataset to use for analysis. The results on PFV (WT) and PFV (IV) are given 137 
in Figure 3c. The results obtained for all retroviruses reveal similarities between the non-138 
palindromic motifs. 139 
 140 
 141 
 142 
 143 
The factors that influence the pattern of integration of retroviruses and transposable elements 144 
operate at different physical scales. The strength of association between specific genomic 145 
features and retroviral integration frequency depends on the genomic scale on which the data are 146 
analyzed 20,26. Broadly, three scales have been studied: chromosome domains and 147 
euchromatin/heterochromatin; genomic features such as histone modifications and transcription 148 
factor binding sites; and primary DNA sequence. 149 
 150 
 151 
The primary DNA sequence of the host genome is thought to influence the site of 152 
retroviral integration by determining both the binding affinity of the intasome and the physical 153 
7 
characteristics of the target DNA, especially the ability of the double helix to bend 7,27, which 154 
depends in turn on the presence of specific dinucleotides and trinucleotides. Muller and Varmus 155 
28 concluded that the bendability of DNA could explain the preferential integration of certain 156 
retroviruses in DNA associated with nucleosomes. The requirement for DNA bending during 157 
retroviral integration has been explained by the discovery of the crystal structure of the foamy viral 158 
intasome complexed with target DNA 29,30. Complete unstacking of the central dinucleotide at 159 
the site of integration allows the scissile phosphodiester backbone to reach the active sites of 160 
the IN protomers 36.  Although the bending of the tDNA observed in the crystal structure 161 
does not correspond with the bend described in nucleosomal DNA 31, the cryo-electron 162 
microscopy structure of the foamy viral intasome in complex with mononucleosomes 25 showed 163 
that the nucleosomal DNA is lifted from the histone octamer to allow proper accommodation 164 
within the active sites of the IN protomers. Given that integration catalyzed by different retroviral 165 
INs gives rise to a different target duplication size, it is expected that DNA bending at the site of 166 
integration will be more severe for integrations with a 4 bp target duplication compared to those 167 
with a 6 bp target duplication 29. 168 
 169 
 170 
Whereas some retroviruses preferentially integrate into regions of dense nucleosome packing 171 
(e.g.  PFV, MLV)25, others prefer regions of sparse nucleosome packing (e.g.  HIV, ASV; 32). 172 
However, even in cases where nucleosome sparseness is preferred, a nucleosome at the integration 173 
site itself contributes to efficient integration. 174 
 175 
In addition to the impact of specific dinucleotides and trinucleotides on DNA bendability, 176 
the other chief impact of primary DNA sequence on retroviral integration is the presence of a 177 
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primary DNA motif, i.e. preferred nucleotides at specific positions in relation to the integration 178 
site. Palindromic DNA sequences have been reported at the insertion site of transposable 179 
elements in Drosophila 7, yeast 8,9  and retroviruses 2-6,19. The presence of the palindrome has 180 
been attributed by several workers to the symmetry of the multimeric viral preintegration 181 
complex2,3. However, Liao et al.7
 
noted that, although the palindromic pattern that they 182 
observed at the insertion site of a P transposable element in Drosophila could be discerned 183 
when as few as fifty insertion sites were aligned and averaged, the palindrome was not evident 184 
at the level of a single insertion site. 185 
 186 
 187 
It was previously assumed that the non-appearance of the palindromic nucleotide sequence in 188 
individual retroviral integration sites was due to the fact that the palindrome was weak, i.e. 189 
poorly conserved.  However, in the present study we found evidence that the palindrome was 190 
statistically significantly disfavored at the level of individual sites:  the palindrome is evident 191 
only as an average – a consensus – of the population of integration sites.  We propose that the 192 
most likely explanation is that the palindrome results from a mixture of sequences that contain a 193 
non-palindromic nucleotide motif in approximately equal proportions on the plus-strand and the 194 
minus-strand of the genome.  In fact, while the integrase components of the in vitro purified 195 
intasome form a highly symmetrical structure, within the in vivo pre-integration complex, which 196 
also includes other viral and host proteins, a degree of asymmetry is imposed by the presence of 197 
the retroviral DNA; this asymmetry may be sufficient to favor a non-palindromic sequence at the 198 
integration site. 199 
On the hypothesis of a non-palindromic nucleotide motif in approximately equal proportions on 200 
the plus-strand and the minus-strand of the genome, we sorted the populations of sequences of 201 
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several different retroviral integration sites into those with a conserved motif respectively on the 202 
plus-strand and the minus-strand of the genome. The resulting alignment revealed the putative true 203 
nucleotide motif that is recognized by the intasome in each case. Comparison of these motifs 204 
between the respective viruses showed certain similarities between the sequences (Figure 3), 205 
including two T residues upstream of the integration site and an A residue 2 or 3 nucleotides 206 
downstream.  There is a shared motif 5’- T(N1/2)[C(N0/1)T | (W1/2)C]CW - 3’, where [ and ] 207 
represent the start and end of the duplicated region, W  d e n o t e s  A  o r  T ,  and | represents 208 
the axis of symmetry.  The preference for an A (T) 2 or 3 nucleotides downstream (upstream) 209 
of the integration site was previously observed and explained by a direct contact between A and 210 
the residue at the PFV IN Ala188 equivalent position 29,30,33.  Indeed, the recent X-ray structure 211 
of the post-strand-transfer complex of the alpharetrovirus Rous Sarcoma Virus (RSV) IN 212 
illustrates a direct contact with an A (T) 3 nucleotides downstream (upstream) of the integration 213 
site and the homologous Ser124 residue site 34.   Using the same algorithm on InS sequences 214 
generated with HIV-1 IN Ser119Thr (equivalent to PFV IN Ala188) 33 the shared motif is 215 
preserved (Supplementary Figure 5), with a stronger preference for an A(T) 3 nucleotides 216 
downstream (upstream) of the InS.  It remains to be seen whether the nucleotide composition 217 
of the remainder of the shared motif, in particular the central T-rich region, is preferred 218 
because of the flexibility of the DNA at such sequences or is due to direct contact between 219 
IN and the bases.  Further structural information on lenti-, gamma-, and delta-retroviral synaptic 220 
complexes is needed to answer this question. 221 
 222 
To summarize, we conclude that, in contrast to the palindromic sequence motifs that are bound by 223 
many transcription factors, the primary DNA motif recognized by the retroviral intasome is non-224 
10
 
palindromic. 225 
 226 
 227 
 228 
 229 
 230 
Methods 231 
 232 
 233 
 234 
Mapped integration sites To focus on the initial integration targeting profile of HTLV-1 and HIV- 235 
 236 
 237 
1, integration sites were identified in DNA purified from cells infected experimentally in vitro. 238 
Jurkat T-cells were infected either by short co-culture with HTLV-1-producing cell line MT2 35
 
or 239 
by VSV-G pseudotyped HIV-1 (kind gift from Dr. Ariberto Fassati, UCL). Identification of 4,521 240 
HTLV-1 integration sites from in vitro infected Jurkat T-cells has been described before 15,36. 241 
Identification of 13,442 HIV-1 integration sites was carried out using a similar approach, using the 242 
following HIV-specific PCR forward primers: HIVB3 5’-243 
GCTTGCCTTGAGTGCTTCAAGTAGTGTG-3’, HIVP5B5 5’-244 
AATGATACGGCGACCACCGAGATCTACACGTGCCCGTCTGTTGTGTGACTCTGG-3’ and 245 
HIV-specific sequencing primer 5’-ATCCCTCAGACCCTTTTAGTCAGTGTGGAAAATCTC-246 
3’. 247 
Credible intervals for entries of the PPM To obtain the credible intervals given in Figures 1d 248 
and 1h, we regard the elements of the PPM as parameters, which we then infer using Bayesian 249 
methods.  Let ݌௑,௞	denote the probability that nucleotide ܺ ∈ 	 {ܣ, ܶ, ܥ, ܩ} is observed in position 250 
݇, and define ݊௑,௞ to be the number of times ܺ was observed in position ݇.  For column ݇ of the 251 
PPM, which we denote ࢖࢑ = ൣ݌஺,௞	݌்,௞	݌஼,௞	݌ீ,௞൧, we know that each ݌௑,௞ ≥ 0	and that 252 
∑ ݌௑,௞௑∈	{஺,்,஼,ீ} = 1, so a Dirichlet prior is appropriate.  We take a symmetric Dirichlet prior 253 
with ߙ = 1	(which is equivalent to a uniform prior).  Assuming [݊஺,௞	்݊,௞	݊஼,௞	݊ீ,௞] are jointly 254 
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distributed according to a multinomial distribution with ݊TOTAL = ∑ ݊௑,௞	௑∈	{஺,்,஼,ீ} trials and 255 
probabilities ൣ݌஺,௞	݌்,௞	݌஼,௞	݌ீ,௞൧, it can be shown that the marginal posterior distributions for 256 
the entries of column ݇ of the PPM are ݌௑,௞~Beta(1 + ݊௑,௞, 4	 +	݊TOTAL − (1 + ݊௑,௞)).  Using 257 
these, we find 95% highest posterior density (HPD) regions using the betaHPD function from 258 
the pscl package 37 in the R statistical programming language 38. 259 
Adjusted Palindrome Index (API) We define the palindrome index (PI) for a sequence to be 260 
the proportion of positions at which it is equal to its reverse complement.  For example, the PI 261 
for the sequence s = ATCCGGTT is 0.75, since the reverse complement sequence is s’ = 262 
AACCGGAT, and s and s’ are identical at 6 out of the 8 positions (6/8 = 0.75).  For sequences 263 
of odd length, we first remove the central letter.  Hence sequences may be assumed to be of even 264 
length.  The adjusted palindrome index (API) is a “corrected for chance” version of the PI, 265 
which controls for the fact that the expected value of the PI depends upon the length of the 266 
sequence.  Such adjusted indexes are common (e.g. 39), and are calculated as: Adjusted Index = 267 
(Observed Index – Expected Index)/(Maximum Index – Expected Index).  For the PI, the 268 
maximum value is 1 (when a sequence is perfectly palindromic). Given sequence ݏ =269 
	ߪି௡ …ߪିଵߪାଵ. . . ߪା௡, the expected value for the PI is the expectation when ߪା௝ and ߪି௝ are 270 
independent, which is given by ଵ௡ ∑ ൫∑ ݌	(ߪି௝ = ܺ)	݌	(ߪା௝ = ܿ	(ܺ))௑∈	{஺,்,஼,ீ} ൯௡௝ୀଵ .  Here ܿ	(ܺ) 271 
denotes the complement of ܺ, and ݌	(ߪ±௝ = ܺ)	are the empirical marginal probabilities, which 272 
may be taken from the entries of the PPM.  273 
Two-component mixture model We model the InS sequences as being drawn from a 2-274 
component mixture model, ݌(ݏ|ܲ, ߣ) = 	ߣ݂(ݏ|ܲ) + (1 − ߣ)݂൫ݏหܲ(ோ஼)൯, where ݂(ݏ|ܲ) is the 275 
likelihood of sequence ݏ given PPM ܲ, and ܲ(ோ஼) denotes the reverse complement of PPM ܲ 276 
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(which follows automatically from ܲ by reversing the order of the columns, and swapping the A 277 
and T rows with one another, and the C and G rows with one another).   We define the 278 
likelihood straightforwardly as the product of probabilities of each of the elements of ݏ, where 279 
the individual probabilities are given by the entries of the PPM.  To fit the model, we must 280 
estimate the parameters ߣ and ܲ.  We find the maximum likelihood estimates of these 281 
parameters using the expectation maximization algorithm. 282 
 Expectation-maximization (EM) algorithm for our model  We refer the reader to 40 for 283 
general information about the EM algorithm, and here provide the update equations for the 284 
model parameters, ߣ and ܲ.  Suppose we have a collection of ܰ InS sequences, ݏ(ଵ), …	, ݏ(ே).  At 285 
iteration ݐ, define ݓ௧(௜)	to be the posterior probability of sequence ݏ(௜) belonging to the 286 
subpopulation with PPM ܲ, given ߣ௧ିଵ and ௧ܲିଵ (the parameter estimates at iteration ݐ − 1).  287 
That is, ݓ௧(௜) = ఒ೟షభ௙൫௦
(೔)ห௉೟షభ൯
ఒ೟షభ௙൫௦(೔)ห௉೟షభ൯ାఒ೟షభ௙ቀ௦(೔)ቚ௉೟షభ(ೃ಴)ቁ
.  Also, for ܺ ∈ 	 {ܣ, ܶ, ܥ, ܩ} and ݇ = 1,… , ݊ (or 288 
݇ = 0,… , ݊ in the odd palindrome case), we define ܳ௧(௞,௑) = 	∑ ൬ݓ௧(௜)ॴቀߪି௞(௜) = 	ܺቁ +ே௜ୀଵ289 
	ቀ1 −	ݓ௧(௜)ቁॴ ቀߪା௞(௜) = 	ܿ(ܺ)ቁ൰.  Then ߣ௧ = 	∑ ௪೟
(೔)
ே
ே௜ୀଵ , and defining the element of ௧ܲ in column ݇ 290 
and row labeled by nucleotide ܺ to be ௧ܲ(݇, ܺ), we have ௧ܲ(݇, ܺ) = ொ೟(௞,௑)∑ ொ೟(௞,௑)೉	∈	{ಲ,೅,಴,ಸ} . 291 
EM algorithm: Initialization and stopping criteria We initialize the EM algorithm by setting 292 
the initial PPM, ଴ܲ, to be the original (palindromic) PPM, and setting the initial mixture weight, 293 
ߣ଴, to be 0.5.  At iteration ݐ, we calculate the log-likelihood associated with the full dataset using 294 
the current parameter estimates, ℓ୲ 	= 	∑ log(݌(s୧	|	λ୲, P୲))ே௜ୀଵ .  We terminate the algorithm 295 
when	ℓ௧ାଵ −	ℓ୲ < 	τ, for some preset threshold value τ.  To obtain the results shown in Figure 296 
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3, we set τ = 	10ିଵ଴ .  To reduce run-times when finding the null distribution of the likelihood 297 
ratio test (LRT) statistic, we set  τ = 0.1, since it was necessary to run the algorithm a large 298 
number of times.  299 
Likelihood ratio tests for quality of fit Although it is tempting to apply a simple likelihood ratio 300 
test (LRT) to determine if the unconstrained 2-component mixture model provides a significantly 301 
better fit to the data than the constrained, single component palindromic model (in which P  = 302 
P(RC )), it is well known that for mixture models the LRT statistic does not in general follow 303 
standard χ2 distributions 41.  We therefore adopted McLachlan’s approach 42 in order to 304 
construct an empirical null distribution for the LRT statistic, D. Note that here the null model is 305 
a single component with PPM equal to the empirical PPM (given in Figure 1b for HTLV-1 and 306 
Figure 1f for HIV-1), while the alternative is the fitted 2-component mixture model. Briefly, we 307 
simulated 1,000 new datasets using the null model, fitted both the null and alternative models to 308 
each simulated dataset, and calculated the LRT statistic each time.  In this way, we obtained 309 
empirical null distributions for the LRT statistic, which we then used to assess the significance 310 
of the observed LRT statistic. For the HTLV-1 InS sequences, the 1,000 values sampled from the 311 
null distribution of the LRT statistic all fell between -28.64 and 18.79, while the observed LRT 312 
statistic was 1.49 × 103. For the HIV-1 InS sequences, the sampled LRT statistics all fell between -313 
32.37 and 29.24, while the observed LRT statistic was 2.86 × 103. For both the HTLV-1 and HIV-1 314 
datasets we may clearly reject the null model in favor of the alternative model (p < 0.001). 315 
Data Availability.  Data to reproduce the results on HTLV-1 presented in this study are included 316 
with the code (see Code Availability).  All other data that support the findings of this study are 317 
available from the corresponding author upon request. 318 
Code Availability. Code is available from http://www.mrc-bsu.cam.ac.uk/software/bioinformatics-319 
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Figures and Tables: 427 
 428 
 429 
 430 
Figure 1: Palindromic HTLV-1 and HIV-1 target integration site consensus sequences and 431 
position probability matrices (PPMs), calculated from 4,521 HTLV-1 and 13,442 HIV-1 InS 432 
sequences. (a) In agreement with previous studies, we find the HTLV-1 consensus sequence to 433 
be a distinctive weak palindrome. The dashed pink line indicates the palindrome’s axis of 434 
symmetry, while the shaded area indicates the duplicated region.  (b) The PPM, P, for the target 435 
integration sites is also palindromic, i.e. P1,−j  ≈ P2,j , P2,−j  ≈ P1,j , P3,−j  ≈ P4,j and P4,−j  ≈ P3,j for j 436 
= 1, . . . , 13. Sequence positions to the left of the symmetry line are labeled as negative, and 437 
those to the right as positive. (c) The symmetry in the PPM may be conveniently visualized 438 
using a sequence logo, which also highlights that the palindrome is only weak (has low 439 
information content). (d) We plot the entries in the first 13 columns of the PPM, P, against the 440 
corresponding entries in the reverse-complement PPM, P(RC) (i.e. the PPM obtained after first 441 
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taking the reverse complement of all of the sequences).  Uncertainty in the PPM entries is 442 
indicated using blue squares showing the 95% credible interval (highest posterior density) range 443 
(see Methods). A perfectly palindromic PPM would be one for which P(RC)  = P , whose entries 444 
would lie along the diagonal shown in the plot.  (e) – (h): As (a) – (d), but using the HIV-1 445 
integration sites. 446 
  447 
 448 
 449 
Figure 2: Distribution of adjusted palindrome index (API) scores over all 4,521 HTLV-1 450 
integration site sequences (top, taking the sequence length to be 2n = 26, where n is the number 451 
of positions each side of the line of palindromic symmetry), and over all 13,442 HIV-1 452 
integration sequences (bottom, with 2n + 1 = 25).  In both cases, the API for the corresponding 453 
consensus sequence (indicated by the red dashed line) is in the extreme positive tail of the 454 
distribution. 455 
 456 
 457 
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 458 
Figure 3: Summary of results from fitting the 2-component mixture model by maximum 459 
likelihood. (a) Sequence logo summaries of one of the two subpopulations of integration site 460 
sequences in the HTLV-1 and HIV-1 datasets (in each case, the other subpopulation is 461 
characterized by the reverse complement of the sequence logo shown). (b) As (a), but for the 462 
MLV and ASLV datasets. (c) As (a), but for the PFV (WT) and PFV (IV) datasets. 463 
 464 
 465 
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Sequence length API for consensus Mean API, ߩ஺ p-value (ℋ଴) 
26 0.79 -0.01 2.12E-06 
24 0.89 -0.01 2.99E-07 
22 0.87 -0.01 5.31E-07 
20 0.86 -0.02 1.58E-07 
18 0.85 -0.02 1.08E-07 
16 1 -0.02 2.41E-11 
14 1 -0.03 5.00E-15 
12 1 -0.03 1.08E-14 
10 1 -0.04 1.58E-18 
8 1 -0.03 1.15E-14 
6 1 -0.04 5.04E-18 
4 1 -0.05 1.28E-15 
2 1 -0.08 2.83E-21 
 466 
Table 1: Adjusted palindrome index (API) scores for HTLV-1 integration site sequences. We 467 
consider a variety of possible sequence lengths, ranging from 2n = 26 to 2n = 2, where n is the 468 
number of positions each side of the line of palindromic symmetry. The mean API values were 469 
calculated by finding the API for each of the 4,521 individual InS sequences, and then taking the 470 
mean.  The final column contains p-values resulting from one-sample t-tests assessing the null 471 
hypothesis that the population mean value is equal to zero. 472 
 473 
 474 
Sequence length API for consensus Mean API, ߩ஺ p-value (ℋ଴) 
25 0.88 -0.01 8.21E-09 
23 0.87 -0.01 1.60E-08 
21 0.86 -0.01 4.29E-09 
19 0.85 -0.01 1.29E-11 
17 0.83 -0.01 1.08E-12 
15 0.8 -0.02 1.04E-13 
13 1 -0.02 3.16E-18 
11 1 -0.03 1.69E-26 
9 1 -0.03 1.02E-27 
7 1 -0.03 8.57E-25 
5 1 -0.04 1.09E-24 
3 1 -0.07 1.95E-35 
 475 
Table 2: Adjusted palindrome index (API) scores for HIV-1 integration site sequences. 476 
 477 
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